Literature DB >> 6806598

Bacterial toxins: a table of lethal amounts.

D M Gill.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6806598      PMCID： PMC373212          DOI： 10.1128/mr.46.1.86-94.1982

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN： 0146-0749


× No keyword cloud information.
  69 in total

1.  Virulence, toxinogeny, and lysogeny in Corynebacterium diphtheriae.

Authors:  L BARKSDALE; L GARMISE; K HORIBATA
Journal:  Ann N Y Acad Sci       Date:  1960-11-21       Impact factor: 5.691

2.  ENHANCEMENT OF BACTERIAL ENDOTOXIN LETHALITY BY STAPHYLOCOCCAL ENTEROTOXIN.

Authors:  H SUGIYAMA; E M MCKISSIC; M S BERGDOLL; B HELLER
Journal:  J Infect Dis       Date:  1964-04       Impact factor: 5.226

3.  Purification of the third factor of anthrax toxin.

Authors:  H SMITH; J L STANLEY
Journal:  J Gen Microbiol       Date:  1962-11

4.  [New investigations on botulinism and its five toxic types].

Authors:  A R PREVOT; E R BRYGOO
Journal:  Ann Inst Pasteur (Paris)       Date:  1953-11

5.  Studies with Shigella dysenteriae (Shiga) infection and intoxication in Macacus mulatta monkeys.

Authors:  S E BRANHAM; K HABEL; R D LILLIE
Journal:  J Infect Dis       Date:  1949 Nov-Dec       Impact factor: 5.226

6.  Biological activities contaminating preparations of phospholipase C ( -toxin) from Clostridium perfringens.

Authors:  R Möllby; C E Nord; T Wadström
Journal:  Toxicon       Date:  1973-02       Impact factor: 3.033

7.  Clinical chemistry of staphylococcal enterotoxin poisoning in monkeys.

Authors:  G J Crawley; J N Black; I Gray; J W Blanchard
Journal:  Appl Microbiol       Date:  1966-05

8.  Cereolysin: production, purification and partial characterization.

Authors:  A W Bernheimer; P Grushoff
Journal:  J Gen Microbiol       Date:  1967-01

9.  Purification and characterization of two components of botulinum C2 toxin.

Authors:  I Ohishi; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

10.  Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes.

Authors:  I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441
View more
  189 in total

1.  Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Jung-Ja P Kim; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.

Authors:  Daniel M Held; Amy C Shurtleff; Scott Fields; Christopher Green; Julie Fong; Russell G A Jones; Dorothea Sesardic; Roland Buelow; Rae Lyn Burke
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

3.  Llama-derived single-domain antibodies for the detection of botulinum A neurotoxin.

Authors:  Marla D Swain; George P Anderson; Dan Zabetakis; Rachael D Bernstein; Jinny L Liu; Laura J Sherwood; Andrew Hayhurst; Ellen R Goldman
Journal:  Anal Bioanal Chem       Date:  2010-06-28       Impact factor: 4.142

4.  Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

Authors:  James S Henkel; William H Tepp; Amanda Przedpelski; Robert B Fritz; Eric A Johnson; Joseph T Barbieri
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

5.  Structural analysis of botulinum neurotoxin type G receptor binding .

Authors:  John Schmitt; Andrew Karalewitz; Desirée A Benefield; Darren J Mushrush; Rory N Pruitt; Benjamin W Spiller; Joseph T Barbieri; D Borden Lacy
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

6.  The genome sequence of Clostridium botulinum type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny.

Authors:  Yoshihiko Sakaguchi; Tetsuya Hayashi; Ken Kurokawa; Keisuke Nakayama; Kenshiro Oshima; Yukako Fujinaga; Makoto Ohnishi; Eiichi Ohtsubo; Masahira Hattori; Keiji Oguma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-15       Impact factor: 11.205

7.  Elimination of botulinum neurotoxin (BoNT) type B from drinking water by small-scale (personal-use) water purification devices and detection of BoNT in water samples.

Authors:  Ari Hörman; Mari Nevas; Miia Lindström; Marja-Liisa Hänninen; Hannu Korkeala
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

Review 8.  Evidence based medicine on the use of botulinum toxin for headache disorders.

Authors:  W J Schulte-Mattler; E Leinisch
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

9.  Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin.

Authors:  J W Ezzell; B E Ivins; S H Leppla
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

10.  Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

Authors:  A Nowakowski; C Wang; D B Powers; P Amersdorfer; T J Smith; V A Montgomery; R Sheridan; R Blake; L A Smith; J D Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.